A multicenter observational study of the real‐world use of docetaxel for metastatic castration‐resistant prostate cancer in China

AIM: To investigate the use of docetaxel for the treatment of metastatic castration‐resistant prostate cancer (mCRPC) in real‐world clinical practice in China. METHODS: This single‐arm, prospective, observational study was conducted at 32 study centers in China and included male patients aged ≥18 ye...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Dalin, Sun, Zhongquan, Guo, Jianming, Zhang, Zhigen, Shan, Yuxi, Ma, Lulin, Li, Hanzhong, Jin, Jie, Huang, Yiran, Xiao, Jiaquan, Wei, Qiang, Ye, Dingwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850484/
https://www.ncbi.nlm.nih.gov/pubmed/30873737
http://dx.doi.org/10.1111/ajco.13142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850484/
https://www.ncbi.nlm.nih.gov/pubmed/30873737
http://dx.doi.org/10.1111/ajco.13142

Ejemplares similares